AIM
PFE icon

Alphinity Investment Management’s Pfizer PFE Stock Holding History

Alphinity Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-760,875
Closed -$31.8M – 28
2018
Q3 		$31.8M Sell
760,875
-208,952
-22% -$8.04M 6.06% 2
2018
Q2 		$33.4M Buy
969,827
+68,112
+8% +$2.33M 6.77% 1
2018
Q1 		$30.4M Buy
+901,715
New +$31M 6.89% 1

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alphinity Investment Management's PFE Position: Q4 2018 in Review

Alphinity Investment Management sold out of Pfizer (PFE) in Q4 2018, closing a stake of 760,875 shares — an estimated $31.8M sold.

Alphinity Investment Management first reported a position in PFE in Q1 2018 and held it in 3 quarters. The position peaked at $33.4M in Q2 2018. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Alphinity Investment Management reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
  • Alphinity Investment Management sold 760,875 Pfizer shares in Q4 2018, an estimated $31.8M.
  • Alphinity Investment Management first reported a position in Pfizer in Q1 2018 and held it in 3 quarters.
  • Alphinity Investment Management's Pfizer position peaked at $33.4M in Q2 2018.
  • 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Alphinity Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.